Pliant Therapeutics Inc Forecast, price target & analysts
Pliant Therapeutics Inc Target price 2024 - Analyst rating & recommendation
Pliant Therapeutics Inc Classifications & Recommendation:
Pliant Therapeutics Inc Target price
| Target price | $41.82 |
| Course | $10.75 |
| Price potential |
289.01%
register free of charge
|
| Number of estimates | 11 |
|
11 Analysts have issued a price target Pliant Therapeutics Inc 2025 .
The average Pliant Therapeutics Inc target price is $41.82.
This is
289.01%
register free of charge
$48.00
346.51%
register free of charge
$32.00
197.67%
register free of charge
|
|
| A rating was issued by 13 analysts: 13 Analysts recommend Pliant Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Pliant Therapeutics Inc share has an average upside potential 2025 of
289.01%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 1.58 | 1.83 |
| 83.69% | 15.54% | |
| EBITDA margin | -11,537.97% | -12,420.42% |
| 805.14% | 7.65% | |
| Net margin | -10,498.73% | -11,502.77% |
| 473.66% | 9.56% |
11 Analysts have issued a sales forecast Pliant Therapeutics Inc 2024 . The average Pliant Therapeutics Inc sales estimate is
This results in the following potential growth figures:
2 Analysts have issued an Pliant Therapeutics Inc EBITDA forecast 2024. The average Pliant Therapeutics Inc EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
4 Pliant Therapeutics Inc Analysts have issued a net profit forecast 2024. The average Pliant Therapeutics Inc net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -2.75 | -3.48 |
| 6.46% | 26.55% | |
| P/E ratio | negative | |
| EV/Sales | 120.94 |
4 Analysts have issued a Pliant Therapeutics Inc forecast for earnings per share. The average Pliant Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Pliant Therapeutics Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Pliant Therapeutics Inc...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
